These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 21122382)

  • 1. [Expression of EVEC in ovarian carcinoma and its biological significance].
    Wang Q; Li XG; Zhang Y; Cao LQ; Deng ZH; Chen Y
    Zhonghua Zhong Liu Za Zhi; 2010 Sep; 32(9):676-80. PubMed ID: 21122382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression and clinical significance of endostatin and vascular endothelial growth factor in ovarian carcinoma].
    Shi HR; Song WJ; Chen ZM; Wu QH
    Ai Zheng; 2005 Sep; 24(9):1127-31. PubMed ID: 16159439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression and clinical significance of TLR9 in ovarian cancer].
    Sha HL; Ouyang WX; Lü G
    Zhonghua Zhong Liu Za Zhi; 2010 Dec; 32(12):913-6. PubMed ID: 21223799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlation of DPPIV expression with clinicopathological features and prognosis in epithelial ovarian carcinoma].
    Zhang MZ; Qiao YH; Suo ZH
    Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):848-52. PubMed ID: 19173831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Correlation of hK6 expression with clinicopathological features and prognosis in epithelial ovarian cancer].
    Hu CJ; Zhang F; Chen YJ; Sun XM; Zheng JF
    Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):520-3. PubMed ID: 19950700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Human pituitary tumor transforming gene 1 expression in ovarian carcinoma and its clinical significance].
    Cheng YX; Feng J; Zhang XY; Fu TY; Yao Y
    Ai Zheng; 2004 Sep; 23(9):1026-30. PubMed ID: 15363195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p21WAF1/CIP1 protein expression in primary ovarian cancer.
    Ferrandina G; Stoler A; Fagotti A; Fanfani F; Sacco R; De Pasqua A; Mancuso S; Scambia G
    Int J Oncol; 2000 Dec; 17(6):1231-5. PubMed ID: 11078810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
    Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
    Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Correlation of genetic instability of nm23H1 gene to clinicopathologic features of epithelial ovarian carcinoma].
    Yang YQ; Li JC
    Ai Zheng; 2006 Jun; 25(6):713-7. PubMed ID: 16764766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
    Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
    Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expressions of Cx43 and Skp2 in epithelial ovarian tumor and their clinical significances].
    Hu YQ; Liu YJ
    Ai Zheng; 2005 Jan; 24(1):104-9. PubMed ID: 15642212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression and clinical significance of uPA and PAI-1 in epithelial ovarian cancer].
    Cai Z; Li YF; Liu FY; Feng YL; Hou JH; Zhao MQ
    Ai Zheng; 2007 Mar; 26(3):312-7. PubMed ID: 17355798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of mesothelin mRNA and protein in ovarian carcinomas].
    Bi SN; Dai SZ; Yao Q; Che YC; Wang N
    Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):288-91. PubMed ID: 18788634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human kallikrein 8 (hK8/TADG-14) expression is associated with an early clinical stage and favorable prognosis in ovarian cancer.
    Shigemasa K; Tian X; Gu L; Tanimoto H; Underwood LJ; O'Brien TJ; Ohama K
    Oncol Rep; 2004 Jun; 11(6):1153-9. PubMed ID: 15138549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of TGFß1 and its receptors is associated with biological features of ovarian cancer and sensitivity to paclitaxel/carboplatin.
    Komiyama S; Kurahashi T; Ishikawa M; Tanaka K; Komiyama M; Mikami M; Udagawa Y
    Oncol Rep; 2011 Apr; 25(4):1131-8. PubMed ID: 21249319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression of six biomarkers in the four most common ovarian cancers: correlation with clinicopathological parameters.
    Lin CK; Chao TK; Yu CP; Yu MH; Jin JS
    APMIS; 2009 Mar; 117(3):162-75. PubMed ID: 19245589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic and genetic alterations of p33ING1b in ovarian cancer.
    Shen DH; Chan KY; Khoo US; Ngan HY; Xue WC; Chiu PM; Ip P; Cheung AN
    Carcinogenesis; 2005 Apr; 26(4):855-63. PubMed ID: 15677627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of hSef and FGF-2 in epithelial ovarian tumor].
    Feng QL; Shi HR; Qiao LJ; Zhao J
    Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):770-4. PubMed ID: 22335910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B7-H4 overexpression in ovarian tumors.
    Tringler B; Liu W; Corral L; Torkko KC; Enomoto T; Davidson S; Lucia MS; Heinz DE; Papkoff J; Shroyer KR
    Gynecol Oncol; 2006 Jan; 100(1):44-52. PubMed ID: 16256178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative expression levels of Th1 and Th2 cytokine mRNA are independent prognostic factors in patients with ovarian cancer.
    Kusuda T; Shigemasa K; Arihiro K; Fujii T; Nagai N; Ohama K
    Oncol Rep; 2005 Jun; 13(6):1153-8. PubMed ID: 15870936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.